Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.82 |
| ▸ | CA9 | Q16790 | 3/20 | 0.82 |
| ▸ | HK1 | P19367 | 2/20 | 0.54 |
| ▸ | HK2 | P52789 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.51 |
| ▸ | SNCA | P37840 | 1/20 | 0.49 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16011460 | 1.00 | CA2 (0.82) | CA2CA9HK1HK2CA1 | |
| SCHEMBL16011459 | 1.00 | CA2 (0.82) | CA2CA9HK1HK2CA1 | |
| SCHEMBL16025456 | 0.90 | CA2 (0.81) | CA2CA9HK1HK2CA1 | |
| SCHEMBL16025457 | 0.89 | CA2 (0.79) | CA2CA9HK1HK2CA1 | |
| SCHEMBL16011464 | 0.88 | CA9 (0.70) | CA2CA9HK1HK2CA1 | |
| SCHEMBL16025433 | 0.88 | CA9 (0.70) | CA2CA9HK1HK2CA1 | |
| SCHEMBL16025459 | 0.88 | CA2 (0.76) | CA2CA9HK1HK2CA1 | |
| SCHEMBL16011463 | 0.88 | CA9 (0.70) | CA2CA9HK1HK2CA1 | |
| SCHEMBL16025454 | 0.87 | CA2 (0.75) | CA2CA9HK1HK2CA1 | |
| SCHEMBL16025453 | 0.86 | CA9 (0.71) | CA2CA9HK1HK2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160007600-A1 | SYNTHETIC LIPOCHITOOLIGOSACCHARIDE ANALOGS FOR ENHANCING PLANT PERFORMANCE | DU PONT (US) | 2016-01-14 | — | — | US | disclosed |
| US-20160007600-A1 | SYNTHETIC LIPOCHITOOLIGOSACCHARIDE ANALOGS FOR ENHANCING PLANT PERFORMANCE | DU PONT (US) | 2016-01-14 | — | — | US | disclosed |
| WO-2014138490-A1 | SYNTHETIC LIPOCHITOOLIGOSACCHARIDE ANALOGS FOR ENHANCING PLANT PERFORMANCE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2014-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160007600-A1 | SYNTHETIC LIPOCHITOOLIGOSACCHARIDE ANALOGS FOR ENHANCING PLANT PERFORMANCE | LIPC, DDOST, MAGT1 | CA2 4069/4885CA9 2976/4885HK1 273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.